Evidence map›Paper›PMID 34761531›Full record

ArticleInfluenza and other respiratory viruses2022

Community predictors of COVID-19 cases and deaths in Massachusetts: Evaluating changes over time using geospatially refined data.

Keith R Spangler, Prasad Patil, Xiaojing Peng, Jonathan I Levy, Kevin J Lane, Koen F Tieskens, Fei Carnes, R Monina Klevens, Elizabeth A Erdman, T Scott Troppy and 2 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Keith R SpanglerDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Prasad PatilDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Xiaojing PengDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Jonathan I LevyDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Kevin J LaneDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Koen F TieskensDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Fei CarnesDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
R Monina KlevensBureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
Elizabeth A ErdmanOffice of Population Health, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
T Scott TroppyBureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
M Patricia FabianDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Jessica H LeiblerDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-0605-0928

Funding

Project 3: Cumulative Risk and Geospatial Health Disparities Related to Chemical and Non-Chemical Stressor ExposuresP50MD010428 · NIMHD · HARVARD SCHOOL OF PUBLIC HEALTH · PI LADEN, FRANCINE, LEVY, JONATHAN I · 2015 to 2020
$4.0M
Nurses Health Study 3: A multiple exposure environmental epidemiology cohort of young adultsR24ES028521 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI CHAVARRO, JORGE EDUARDO, LADEN, FRANCINE · 2018 to 2022
$2.1M
Google LLCNIEHS NIH HHS R24 ES028521NIMHD NIH HHS P50 MD010428NIMHD NIH HHS P50MD010428
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has highlighted the need for targeted local interventions given substantial heterogeneity within cities and counties. Publicly available case data are typically aggregated to the city or county level to protect patient privacy, but more granular data are necessary to identify and act upon community-level risk factors that can change over time.

methodsIndividual COVID-19 case and mortality data from Massachusetts were geocoded to residential addresses and aggregated into two time periods: "Phase 1" (March-June 2020) and "Phase 2" (September 2020 to February 2021). Institutional cases associated with long-term care facilities, prisons, or homeless shelters were identified using address data and modeled separately. Census tract sociodemographic and occupational predictors were drawn from the 2015-2019 American Community Survey. We used mixed-effects negative binomial regression to estimate incidence rate ratios (IRRs), accounting for town-level spatial autocorrelation.

resultsCase incidence was elevated in census tracts with higher proportions of Black and Latinx residents, with larger associations in Phase 1 than Phase 2. Case incidence associated with proportion of essential workers was similarly elevated in both Phases. Mortality IRRs had differing patterns from case IRRs, decreasing less substantially between Phases for Black and Latinx populations and increasing between Phases for proportion of essential workers. Mortality models excluding institutional cases yielded stronger associations for age, race/ethnicity, and essential worker status.

conclusionsGeocoded home address data can allow for nuanced analyses of community disease patterns, identification of high-risk subgroups, and exclusion of institutional cases to comprehensively reflect community risk.

Indexed as

COVID-19Health Status DisparitiesHumansMassachusettsPandemicsSARS-CoV-2census tractCOVID-19disparitiesgeocodingrace/ethnicitySARS-CoV-2

Identifiers

PMID34761531
PMCPMC8652977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.